✦ LIBER ✦

Juvenile Parkinson's disease and its response to L-dopa therapy

✍ Scribed by J. J. M. Askenasy; L. Mendelson; O. Keren; Z. Braun

Publisher: Springer
Year: 1990
Tongue: English
Weight: 595 KB
Volume: 2
Category: Article
ISSN: 1435-1463
DOI: 10.1007/bf02251243

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dementia and treatment with L-dopa in Pa

Dementia and treatment with L-dopa in Parkinson's disease

✍ M. Hietanen; Dr. H. Teräväinen 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 536 KB

We compared the neuropsychological performance of patients with Parkinson's disease who were young at onset of the disease (mean age, 41.4 years) and had received prolonged L-dopa treatment (mean, 52.1 months) with nontreated patients of the same age. A similar comparison was made for patients who w

l-Dopa induces under-damped visually gui

l-Dopa induces under-damped visually guided motor responses in Parkinson’s disease

✍ Wing-Lok Au; Ni Lei; Meeko M. K. Oishi; Martin J. McKeown 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 290 KB

Targeting dopa-sensitive and dopa-resist

Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: Selective responses to internal and external cues

✍ Lynn Rochester; Katherine Baker; Alice Nieuwboer; David Burn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

## Abstract ## Background: Independence of certain gait characteristics from dopamine replacement therapies highlights its complex pathophysiology in Parkinson's disease (PD). We explored the effect of two different cue strategies on gait characteristics in relation to their response to dopaminerg

The effects of cisapride on plasma L-dop

The effects of cisapride on plasma L-dopa levels and clinical response in Parkinson's disease

✍ Walter Diaz Neira; Vicenta Sanchez; Maria Angeles Mena; Dr. Justo Garcia de Yebe 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 1 views

Cisapride (CIS) is a prokinetic agent that increases gastrointestinal motility in normal individuals and improves constipation in Parkinson's disease (PD). We studied the effects of CIS on the clinical response and the peripheral pharmacokinetics of orally administered L-dopa given to patients with

Single-dose L-dopa response in early par

Single-dose L-dopa response in early parkinson's disease: Measurements with optoelectronic recording technique

✍ Dr. Bo Johnels; Páll E. Ingvarsson; Björn Holmberg; Michael Matousek; Göran Steg 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 536 KB

## Abstract Twenty‐five patients with suspected Parkinson's disease were submitted to optoelectronic movement analysis with the Posturo‐ Locomotor‐Manual (PLM) test before and 60 min after a single dose of L‐Dopa. They were then examined clinically for diagnosis. Two patients were excluded due to L

On the relationship betweenl-DOPA therap

On the relationship betweenl-DOPA therapy and CSF monoamine metabolites in parkinson's disease

✍ C. Casati; A. Agnoli; A. Jori; E. Dolfini 📂 Article 📅 1973 🏛 Springer 🌐 English ⚖ 270 KB